TGA Expands Drug-Tampering Recalls to Arrow, Sandoz

International Pharmaceutical Regulatory Monitor
A A
Following further reports of drug tampering, Australia’s Therapeutic Goods Administration expanded an ongoing recall to include Arrow Pharmaceuticals and Novartis’ Sandoz.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor